BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
Starlink Internet Remains Active in Iran Despite Nationwide Blackout 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Lynas CEO Amanda Lacaze to Retire After 12 Years as Rare Earths Demand Grows 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds 
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals 
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits 
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges 
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny 
ALBANY, N.Y., March 27, 2017 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, will host an Investor Day on April 6, 2017 in New York City, beginning at 8:45am EDT.
AngioDynamics’ leadership team, including Jim Clemmer, President and Chief Executive Officer; Michael Greiner, Executive Vice President and Chief Financial Officer; and the general managers of each of the Company’s three global franchises, will share the long-term growth strategy and insights into the plan to deliver shareholder value through fiscal year 2020.
A live webcast and presentation materials will be available on the investor relations section of the Company's website under "Events & Presentations" at investors.angiodynamics.com/events. A replay and transcript of the webcast will be available shortly after the event.
Institutional investors and analysts who wish to attend the Investor Day in-person can contact AngioDynamics via telephone at 1-518-795-1418 or email at [email protected].
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. More information is available at AngioDynamics.com.
Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Company Contact: AngioDynamics Inc. Caitlin Stefanik (518) 795-1418 [email protected] Investor Relations Contacts: FTI Consulting Jim Polson (312) 553-6730 [email protected], Kotaro Yoshida (212) 850-5690 [email protected] Media Contact: FTI Consulting Kimberly Ha (212) 850-5612 [email protected]
